{"text": ["MARKETS:", "Don't", "freak", "out", "about", "today's", "selloff,", "but", "retail", "is", "still", "in", "trouble"], "created_at": "2018-10-04 22:28:25"}
{"text": ["Top", "Performing", "ETFs", "of", "the", "Third", "Quarter"], "created_at": "2018-10-04 20:56:34"}
{"text": ["Top", "Performing", "ETFs", "of", "the", "Third", "Quarter"], "created_at": "2018-10-04 20:56:34"}
{"text": ["J&J,", "Arrowhead", "in", "gene-silencing", "drug", "deal", "worth", "up", "to", "$3.7", "billion"], "created_at": "2018-10-04 18:49:33"}
{"text": ["7", "Healthcare", "Stocks", "to", "Buy", "Right", "Now"], "created_at": "2018-10-04 18:24:15"}
{"text": ["Seattle", "Genetics:", "Impact", "of", "the", "Cascadian", "Acquisition"], "created_at": "2018-10-04 17:25:47"}
{"text": ["Stocks", "-", "Apple,", "Amazon", "Fall", "in", "Pre-market;", "Barnes", "&", "Noble", "Surges"], "created_at": "2018-10-04 15:30:00"}
{"text": ["J&J's", "Phase", "III", "Data", "Shows", "Switch", "to", "its", "HIV", "Drug", "Beneficial"], "created_at": "2018-10-04 15:14:33"}
{"text": ["J&J's", "Phase", "III", "Data", "Shows", "Switch", "to", "its", "HIV", "Drug", "Beneficial"], "created_at": "2018-10-04 15:14:33"}
{"text": ["Health-Care", "Stocks\u2019", "High", "Valuations", "May", "Not", "Be", "a", "Problem"], "created_at": "2018-10-04 14:57:00"}
{"text": ["Arrowhead", "Announces", "$3.7B", "License", "Agreement", "With", "Janssen", "For", "Gene-Silencing", "Drug"], "created_at": "2018-10-04 14:12:09"}
{"text": ["J&J&apos;s", "Phase", "III", "Data", "Shows", "Switch", "to", "its", "HIV", "Drug", "Beneficial"], "created_at": "2018-10-04 13:37:01"}
{"text": ["J&J,", "Arrowhead", "in", "gene-silencing", "drug", "deal", "worth", "up", "to", "$3.7", "billion"], "created_at": "2018-10-04 13:19:43"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "AtriCure's", "Guidance,", "Guardant", "Health", "And", "Kodiak", "To", "Debut"], "created_at": "2018-10-04 11:59:50"}
{"text": ["UPDATE:", "Arrowhead", "Pharma", "stock", "surges", "19%", "on", "news", "of", "$3.7", "billion", "license", "agreement", "with", "Janssen"], "created_at": "2018-10-04 11:52:00"}
{"text": ["Eli", "Lilly\u2019s", "Stock", "Performance", "and", "Estimates", "for", "Q3", "2018"], "created_at": "2018-10-04 11:32:27"}
{"text": ["Arrowhead", "Enters", "$3.7", "Bln", "License", "And", "Collaboration", "Deals", "With", "Janssen"], "created_at": "2018-10-04 08:21:00"}
{"text": ["Arrowhead", "Enters", "$3.7", "Bln", "License", "And", "Collaboration", "Deals", "With", "Janssen"], "created_at": "2018-10-04 08:21:00"}
{"text": ["Moody's:", "Biosimilars", "a", "growing", "challenge", "biotech", "drugs,", "with", "European", "market", "developing", "more", "quickly", "than", "the", "US"], "created_at": "2018-10-04 07:20:06"}
